Skip to content
2B

Updated:

20/20 Biolabs, Inc.

20/20 Biolabs, Inc. No founding year, named principals, or wealth origin have been confirmed from public sources. The firm's investment posture, if any, is...

Overview

20/20 Biolabs, Inc. No founding year, named principals, or wealth origin have been confirmed from public sources. The firm's investment posture, if any, is not publicly documented. There are no verified portfolio companies, disclosed asset-class allocations, or known fund structures. Geographic footprint is unknown, and no additional offices or locations have been identified. No data on team size, deployment, or adjacent vehicles (including philanthropic structures) is available in public records. Without a website or LinkedIn presence, operational details remain speculative. 20/20 Biolabs presents as an emerging or niche entity in the life sciences infrastructure space. The lack of public disclosure places it in a pre-transparency phase common among early-stage or privately held service platforms.

General information

Sector focus

BiotechLife Sciences

Frequently asked questions

Where is 20/20 Biolabs headquartered?

The firm's location has not been disclosed in public records. No city, state, or country of operation is confirmed.

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Explore more profiles